Lord, Abbett & Co
ORTX

Lord, Abbett & Co’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Lord, Abbett & Co’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-162,660
Closed -$7.14M – 708
2021
Q2 		$7.14M Sell
162,660
-14,270
-8% -$795K 0.02% 580
2021
Q1 		$12.8M Buy
+176,930
New +$12.6M 0.03% 487

Other funds holding ORTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Lord, Abbett & Co's ORTX Position: Q3 2021 in Review

Lord, Abbett & Co sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2021, closing a stake of 162,660 shares — an estimated $7.14M sold.

Lord, Abbett & Co first reported a position in ORTX in Q1 2021 and held it in 2 quarters. The position peaked at $12.8M in Q1 2021. 79 funds tracked by Wall St. Rank hold ORTX as of Q3 2021.

  • Lord, Abbett & Co reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 162,660 Orchard Therapeutics plc American Depositary Shares shares in Q3 2021, an estimated $7.14M.
  • Lord, Abbett & Co first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2021 and held it in 2 quarters.
  • Lord, Abbett & Co's Orchard Therapeutics plc American Depositary Shares position peaked at $12.8M in Q1 2021.
  • 79 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2021.

Based on Lord, Abbett & Co's 13F filing for Q3 2021, filed 9 Nov 2021.